RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.

Treating Chronic Pain Using the Oska Pulse Device

A double-blind clinical trial with placebo
Page 2 of 2

This double-blind clinical trial with placebo provided information on the efficacy of PEMF therapy in treating chronic pain. There was significantly more reduction in pain in the OSKA Pulse group after 14 days of use than placebo. These results suggested that the OSKA Pulse may be an effective tool in pain attenuation. Data analyses showed interesting trends in subjective pain scores, including a slight increase in pain in the placebo group after day 7, while the OSKA Pulse group, on average, reported a decline in pain intensity.

This trial encountered some limitations. Incomplete trials and participant attrition, though expected, eliminated a number of participant datasets from analyses. These exclusions from analyses decreased statistical power and contributed to lower external validity of the PEMF intervention. Future trials for this device should include larger sample sizes to account for participant dropout. Participants also cited using the OSKA Pulse 4-6 times per day as a possible drawback.

Results suggest the need for further research on the efficacy of PEMF in pain management, and its possible impact on reducing opioid/pharmacological usage in patients with chronic or complex pain. Such adjunctive pain management solutions may be useful in the treatment of certain pain conditions. 

 

View a mini review trial of the OSKA Pulse device as part of PPM's new PainTech column

Last updated on: January 31, 2018
SHOW MAIN MENU
SHOW SUB MENU